Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cancer Treatment Reports|September 1, 1979
Antitumor activity of cis-dichlorodiammineplatinum(II)M K Wolpert-DeFilippesBulletin Du Cancer|January 1, 1979
Nude mouse models as predictors of chemotherapy in man: thymidine and pyrimidinesA Goldin, M K Wolpert-DefilippesResearch Communications in Chemical Pathology and Pharmacology|March 1, 1981
Binding of maytansine to tubulin: competition with other mitotic inhibitorsC M Lin, E Hamel, M K Wolpert-DeFilippesBehring Institute Mitteilungen|May 1, 1984
Potentials and drawbacks of the human tumor stem cell assayR H Shoemaker, M K Wolpert-DeFilippes, J M VendittiJournal of Medicinal Chemistry|March 1, 1980
Quantitative structure--activity correlations of rifamycins as inhibitors of viral RNA-directed DNA polymerase and mammalian alpha and beta DNA polymerasesR S Wu, M K Wolpert-DeFilippes, F R QuinnCancer Research|July 1, 1977
Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidineP Voytek, J A Beisler, M M Abbasi, et al.Cancer Treatment Reports|August 1, 1986
Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexaneW K Anderson, D A Quagliato, R D Haugwitz, et al.Cancer Research|April 1, 1988
Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogueA Rahman, J K Roh, M K Wolpert-DeFilippes, et al.Cancer Research|May 1, 1987
Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapyD P Griswold, M W Trader, E Frei, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIPB J Foster, B J Harding, M K Wolpert-DeFilippes, et al.Pageof 2